ARTICLE | Clinical News
Prezista darunavir regulatory update
November 19, 2012 8:00 AM UTC
Johnson & Johnson's Janssen Therapeutics division said FDA approved an 800 mg once-daily tablet of HIV drug Prezista darunavir. The company plans to launch the product "shortly." Janssen Therapeutics ...